Trial intelligence / Profile preview

Plerixafor for Stem Cell Mobilization in Sibling Donors for Hematological Malignancies

NCT01696461Phase 2Completed

Sponsor
Center for International Blood and Marrow Transplant Research
Start
May 2013
Primary completion
Aug 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of plerixafor in hematological malignancies, sponsored by Center for International Blood and Marrow Transplant Research. Started May 2013; status: completed.

02

Drugs

plerixafor
03

Conditions

hematological malignancies

Beyond the preview

Go deeper on NCT01696461.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01696461.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call